SAVE THE DATE – Roma, 18-19 giugno 2021 Condividi:FacebookTwitterLinkedin Post navigation Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: an exploratory analysis from DAPA HFComparative effectiveness and safety of sodium–glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists in older adults
